Related Experiment Videos
[Antimicrobial prophylaxis in clean surgery]
1Divisione Malattie Infettive, Ospedale San Bortolo, Vicenza.
Le Infezioni in Medicina
|July 8, 2003
Summary
Antibiotic prophylaxis is not routinely needed for clean surgery but recommended for prosthetic procedures. Glycopeptides may be used for methicillin-resistant staphylococci, but evidence is limited, and resistance is a concern.
Area of Science:
- Infectious Diseases
- Surgical Infections
- Antimicrobial Stewardship
Context:
- Antibiotic prophylaxis is standard in specific surgeries like prosthetic cardiac, vascular, and orthopedic procedures.
- Cephalosporins and antistaphylococcal penicillins are conventional choices against staphylococci.
- Increasing rates of methicillin-resistant staphylococci (MRSA) prompt consideration of alternative agents.
Purpose:
- To review the current recommendations and evidence for antibiotic prophylaxis in clean surgery.
- To evaluate the role of glycopeptides in preventing post-surgical infections, particularly in the context of MRSA.
- To discuss the potential risks associated with glycopeptide use, including resistance development.
Summary:
- Prophylaxis is generally not required for clean surgery, with exceptions for prosthetic implant surgeries.
- Cefazolin, cefuroxime, cefamandole, oxacillin, or aminoglycosides are recommended for staphylococcal coverage.
- Glycopeptides are increasingly used for MRSA but require more prospective studies; limited dosing and ultra-short prophylaxis are advised to mitigate resistance risks.
Impact:
- Highlights the need for evidence-based guidelines on antibiotic prophylaxis in surgery.
- Emphasizes the importance of antimicrobial stewardship to combat antibiotic resistance.
- Informs clinical decision-making regarding the selection and duration of prophylactic antibiotics.